학술논문

Tumor kinetic modeling and identification of predictive factors for tumor response to durvalumab in patients with non-small cell lung cancer (NSCLC).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2017, 35 6p. Supplement: 15
Subject
Language
English
ISSN
15277755